Companies / Celularity Inc

Celularity Inc

Nasdaq: CELUCIK 1752828FLORHAM PARK, NJ

Financials · FY2025

Revenue$26.55M
Net income$-91.72M
Total debt$59.64M
Cash$6.17M
Diluted EPS$-3.59
Shares outstanding28.9M

Ownership

28.9M shares outstanding · as of Apr 28, 2026
14.4%Insiders
Ownership
Insiders14.43%4,177,597
Institutions7.62%2,205,894
Public float77.95%22,562,470

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 5

View all →
Insider% of sharesShares
Hariri Robert JCEOChief Executive Officer · Director
9.86%2,853,553
1.80%520,021
1.36%394,150
0.88%256,026
0.53%153,847

Institutional holders 36

View all →

Activity

InsidersInstitutions
What insiders are doing in this stock (Form 4).
DateActorActionSecurityValueShares ΔPosition afterImpact
Apr 13, 2026Hariri Robert J
CEO
OtherClass A Common Stock$1.5K-1K
-0.04%
2,853,553
9.86% of shares
low
Apr 13, 2026Hariri Robert J
CEO
ExerciseClass A Common Stock$0+3K
+0.12%
2,854,735
9.86% of shares
low
Jan 12, 2026Ling Geoffrey M.D.
Director
GrantClass A Common Stock$0+19K
+8.12%
256,026
0.88% of shares
low
Jan 12, 2026Ling Geoffrey M.D.
Director
GrantClass A Common Stock$0+19K
+8.12%
256,026
0.88% of shares
low
Jan 12, 2026Parks Diane L.
Director
GrantClass A Common Stock$0+30K
+6.12%
520,021
1.80% of shares
low
Jan 12, 2026Parks Diane L.
Director
GrantClass A Common Stock$0+30K
+6.12%
520,021
1.80% of shares
low
Jan 12, 2026LeVien Vincent
Director
GrantClass A Common Stock$0+29K
+23.08%
153,847
0.53% of shares
low
Jan 12, 2026Diamandis Peter
Director
GrantClass A Common Stock$0+20K
+5.45%
394,150
1.36% of shares
low

5%+ ownership events

Schedule 13D / 13G
FilerStance% of classSharesDate
Lincoln Alternative Strategies LLCPassive13G/A0

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
CELUCommon StockEquity151190204BBG00P2RTT34